Issue 4/2017
Content (16 Articles)
Telomeres and telomerase in the clinical management of colorectal cancer
C. Piñol-Felis, T. Fernández-Marcelo, J. Viñas-Salas, C. Valls-Bautista
Spotlight on the relevance of mtDNA in cancer
A. Cruz-Bermúdez, R. J. Vicente-Blanco, E. Gonzalez-Vioque, M. Provencio, M. Á. Fernández-Moreno, R. Garesse
Predictive value of hypoxia in advanced head and neck cancer after treatment with hyperfractionated radio-chemotherapy and hypoxia modification
B. Clavo, F. Robaina, D. Fiuza, A. Ruiz, M. Lloret, D. Rey-Baltar, P. Llontop, A. Riveros, J. Rivero, F. Castañeda, S. Quintero, N. Santana-Rodríguez
Sentinel lymph node biopsy as a prognostic factor in non-metastatic colon cancer: a prospective study
O. Estrada, L. Pulido, C. Admella, L.-A. Hidalgo, P. Clavé, X. Suñol
Accelerated hypofractionated radiation therapy (AHRT) for non-small-cell lung cancer: can we leave standard fractionation?
N. Rodríguez de Dios, X. Sanz, P. Foro, I. Membrive, A. Reig, A. Ortiz, R. Jiménez, M. Algara
Reoperations after primary breast conserving surgery in women with invasive breast cancer in Catalonia, Spain: a retrospective study
J. M. Escribà, L. Esteban, J. Gálvez, M. J. Pla, A. Melià, M. Gil-Gil, R. Clèries, L. Pareja, X. Sanz, M. Bustins, J. M. Borrás, J. Ribes
Comparison of clinicopathological features and prognosis of gastric cancer located in the lesser and greater curve
F. Feng, Y. Tian, M. Guo, S. Liu, G. Xu, Z. Liu, G. Zheng, X. Lian, D. Fan, H. Zhang
Hypofractionated boost after whole breast irradiation in breast carcinoma: chronic toxicity results and cosmesis
J. Sanz, N. Rodríguez, P. Foro, J. Dengra, A. Reig, P. Pérez, I. Membrive, A. Ortiz, M. Codinach, M. Algara
Prognostic significance of immune cells in the tumor microenvironment and peripheral blood of gallbladder carcinoma patients
Y. Zhang, C. Ma, M. Wang, H. Hou, L. Cui, C. Jiang, J. Sun, X. Qu
Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma
F. Vand-Rajabpour, N. Sadeghipour, S. Saee-Rad, H. Fathi, P. Noormohammadpour, M. Yaseri, K. K. Hesari, Z. Bagherpour, M. Tabrizi
Effectiveness and safety of aflibercept for metastatic colorectal cancer: retrospective review within an early access program in Spain
J. Feliu, I. Díez de Corcuera, J. L. Manzano, M. Valladares-Ayerbes, J. Alcaide, T. García García, R. Vera, J. Sastre
Medical oncology future plan of the Spanish Society of Medical Oncology: challenges and future needs of the Spanish oncologists
F. Rivera, R. Andres, E. Felip, R. Garcia-Campelo, P. Lianes, A. Llombart, J. M. Piera, J. Puente, C. A. Rodriguez, R. Vera, J. A. Virizuela, M. Martin, P. Garrido
Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer
Y. F. Song, Z. B. Xu, X. J. Zhu, X. Tao, J. L. Liu, F. L. Gao, C. L. Wu, B. Song, Q. Lin
Erratum to: Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions
J. Salvador, J. Aparicio, F. J. Baron, R. García-Campelo, R. Garcia-Carbonero, P. Lianes, A. Llombart, D. Isla, J. M. Piera, M. Muñoz, J. Puente, F. Rivera, C. A. Rodríguez, J. A. Virizuela, M. Martín, P. Garrido